EGF Receptor Activation Decreases Retroviral Gene Transfer through Protein Kinase C-δ

Area of Science:

• Molecular Biology
• Virology
• Gene Therapy

Background:

• Retrovirus vector design has advanced, but host cell interactions are not fully understood.
• Growth factors are explored to improve gene transfer efficiency in non-dividing cells.

Purpose of the Study:

• To investigate the role of Epidermal Growth Factor Receptor (EGFR) signaling in retroviral gene transfer.
• To elucidate the mechanisms by which EGFR ligands affect gene delivery into host cells.

Main Methods:

• Treatment of human epidermal keratinocytes and cell lines with EGFR ligands (EGF, TGF-α, HB-EGF).
• Use of EGFR function-blocking antibodies and tyrosine phosphorylation inhibitors.
• Inhibition of protein kinase C-delta (PKC-δ) and protein kinase C-zeta (PKC-ζ) using chemical inhibitors and siRNA.
• Cell cycle analysis to assess the impact of EGFR activation on cell cycle status.

Main Results:

• EGFR ligands (EGF, TGF-α, HB-EGF) decreased retroviral gene transfer efficiency.
• EGFR blockade or inhibition of tyrosine phosphorylation enhanced gene transfer dose-dependently.
• Inhibition of PKC-δ, but not PKC-ζ, reversed EGF-induced inhibition of gene transfer.
• EGFR activation's effect on gene transfer was independent of the cell cycle.

Conclusions:

• EGFR signaling negatively regulates retroviral gene transfer.
• The inhibitory effect of EGFR activation is mediated through PKC-δ.
• Findings suggest implications for optimizing retroviral gene therapy and developing antiretroviral strategies.